HALIFAX, NS, May 14, 2020
EZB will resell Adaptiiv’s 3D printing software solution in select markets that include Germany, Austria, Switzerland, Italy, Spain, and France. The two companies previously completed compatibility testing between their respective platforms. Adaptiiv has released new features in version 3.0 of its software solution to ensure mutual customers can use the regulated solution.
EZB is a European-based group active in the production and distribution of medical products for the treatment of cancer using brachytherapy. Brachytherapy applies radioactive sources directly to or into the tumor, allowing a high dose to the tumor while sparing the surrounding healthy tissue. For the patient, this means shorter treatment periods, fewer side effects, and a faster recovery.
“We are working with Adaptiiv because 3D printing can provide new solutions to our brachytherapy customer base in Europe that improves treatment and patient care. Adaptiiv is the first company to offer a turnkey platform for patient specific applicators that integrates directly into existing radiotherapy workflows. After our recent launch of 3D printed ready-to-use applicator attachments we continue to work with their team to validate new patient-specific solutions to be used in clinical settings,” says Thomas Osche, Product Manager at EZB.
Adaptiiv has received a CE Mark and FDA 510(k) clearance to market software that is used to 3D print patient-specific radiotherapy accessories. Adaptiiv’s solution represents a step further in enabling patient-specific care by increasing the clinical acceptance and implementation of 3D printing at the point-of-care.
“This represents a major step forward for both of our companies. EZB has recognized the value for their customers of 3D printing with their recent release of 3D printed physician-specific applicator attachments in the EU. Our solution represents an extension of their work by providing our mutual customers with patient-specific 3D printing options. Through this joint effort we are demonstrating that combining our solution platforms with 3D printing is a clinically viable solution to improve the standard of patient care.” says Adaptiiv CTO, Alex Dunphy.
Headquartered in Halifax, Nova Scotia, Canada, Adaptiiv Medical Technologies Inc. is shaping the future of patient-specific healthcare through innovation and collaboration with industry leaders throughout the world. With FDA 510(k) clearance and a CE Mark, Adaptiiv offers a regulated, in-house software solution that has been fully validated to create 3D printed patient-specific radiotherapy accessories. The company’s solution is currently used in a clinical setting by clients in 14 countries.
About Eckert & Ziegler BEBIG
Eckert & Ziegler BEBIG is a European-based group active in the medical device segment of the health care industry. Its core business is the production and distribution of medical products for the treatment of cancer using brachytherapy. The company headquarters are in Germany, with production facilities in Germany and in the USA, as well as offices throughout Europe, Asia and the USA. In addition, Eckert & Ziegler BEBIG has a worldwide network of distributors and agents to support the international marketing and distribution of its product line. The company’s products and equipment are intended for use by oncologists, radiotherapists, urologists, ophthalmologists and medical physicists. Eckert & Ziegler BEBIG employs approximately 145 people.
Adaptiiv Medical Technologies Inc.
+1 (902) 442-9091
Eckert & Ziegler BEBIG
Marketing Communication Manager
Tel.: +49-30-94 10 84 0